PERKI Pekanbaru

50 Followers

acute coronary syndrome secondary prevention stemi statin antiplatelet reperfusion therapy complication rosuvastatin rivaroxaban oral anticoagulant anticoagulant mechanical complication cardiogenic shock metabolic angina trimetazidine echocardiography diagnostic angiotensin receptor blocker congestive heart failure patophysiology thrombosis ems clopidogrel ace inhibitors arrhythmia fibrinolytic primary pci beta blocker enoxaparine enoxaparine coronary heart disease cardiac biomarkers ticagrelor inflammation

Präsentationen
Dokumente
Infografiken

Aktuellste Beliebteste SlideShares

PERKI Pekanbaru

Strategy to Go for Goal in Dyslipidemia with Acute Coronary Syndrome Patients

Secondary Prevention after ACS: Focused on Anticoagulant Therapy

Angina Management with Metabolic Agents

Echocardiography for Acute Coronary Syndrome

Recent Updated Pathogenesis and Management of Heart Failure:

Role of Statin in Secondary Prevention of ACS

Patophysiology of ACS: Role of Thrombosis

Emergency Medical System Network for STEMI Management

New Option of Antiplatelet and Controversies in ACS Treatment

Role of ACE Inhibitors as Secondary Prevention in ACS

Electrical Instability in ACS

Fibrinolytic Therapy

Primary PCI

Haemodynamic Instability in STEMI

Secondary Prevention after ACS - Role of Beta Blockers

Enoxaparin Proven Across the ACS Spectrum

Global Burden of Coronary Heart Disease

Cardiac Biomarkers in ACS

Role of More Potent Antiplatelet in ACS Management

Role of Inflammation in Patophysiology of ACS